Cellectar Biosciences, Inc.Cellectar Biosciences, Inc.Cellectar Biosciences, Inc.

Cellectar Biosciences, Inc.

No trades
See on Supercharts
Market capitalization
‪103.56 M‬USD
−3.11USD
‪−37.98 M‬USD
‪29.22 M‬
Beta (1Y)
1.76

About Cellectar Biosciences, Inc.

CEO
James V. Caruso
Headquarters
Florham Park
Employees (FY)
20
Founded
1996
ISIN
US15117F8077
FIGI
BBG000G9WFQ5
Cellectar Biosciences, Inc. engages in the development of phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. Its portfolio includes CLR 131, which seeks to treat relapse or refractory multiple myeloma, CLR 125, which intends to treat micro metastatic disease, CLR 124 which could detect tumors and metastases in a broad range of cancers and CLR 1502, a cancer-targeting near-infrared-fluorophore optical imaging PDC for intraoperative tumor and tumor margin illumination. The company was founded in June 1996 and is headquartered in Florham Park, NJ.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of CLRB is 3.04 USD — it has decreased by 5.30% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Cellectar Biosciences, Inc. stocks are traded under the ticker CLRB.
Cellectar Biosciences, Inc. is going to release the next earnings report on May 6, 2024. Keep track of upcoming events with our Earnings Calendar.
CLRB stock is 6.64% volatile and has beta coefficient of 1.76. Check out the list of the most volatile stocks — is Cellectar Biosciences, Inc. there?
One year price forecast for Cellectar Biosciences, Inc. has a max estimate of 28.00 USD and a min estimate of 7.00 USD.
CLRB earnings for the last quarter are −0.87 USD whereas the estimation was −0.57 USD which accounts for −52.53% surprise. Estimated earnings for the next quarter are −0.57 USD. See more details about Cellectar Biosciences, Inc. earnings.
Yes, you can track Cellectar Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.
CLRB stock has fallen by 12.89% compared to the previous week, the month change is a 15.08% fall, over the last year Cellectar Biosciences, Inc. has showed a 94.87% increase.
CLRB net income for the last quarter is ‪−7.45 M‬ USD, while the quarter before that showed ‪−13.73 M‬ USD of net income which accounts for 45.76% change. Track more Cellectar Biosciences, Inc. financial stats to get the full picture.
Today Cellectar Biosciences, Inc. has the market capitalization of ‪98.07 M‬, it has decreased by 4.51% over the last week.
No, CLRB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CLRB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cellectar Biosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
CLRB reached its all-time high on Aug 12, 2005 with the price of 13678200.00 USD, and its all-time low was 1.25 USD and was reached on Dec 19, 2022.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 20.00 employees. See our rating of the largest employees — is Cellectar Biosciences, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cellectar Biosciences, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cellectar Biosciences, Inc. stock shows the sell signal. See more of Cellectar Biosciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Cellectar Biosciences, Inc. future price: according to them, CLRB price has a max estimate of 28.00 USD and a min estimate of 7.00 USD. Read a more detailed Cellectar Biosciences, Inc. forecast: see what analysts think of Cellectar Biosciences, Inc. and suggest that you do with its stocks.